Home›Companies›Healthcare›Impruvon

Impruvon, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 5, 2025·Suggest an edit

About Impruvon

Impruvon is a private company based in Baltimore, Maryland, incorporated in 2020 in Delaware. It has reported $2,414,996 raised in one offering on Form D since February 2025. Its chief executive is Justin Amoyal.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 6, 2024Feb 5, 2025$2,414,996of $2.4M target14$172KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Impruvon's Form D filed Feb 5, 2025.

JA
Justin Amoyal
Chief Executive Officer and director
MB

Sources

  1. SECImpruvon, Inc. filing history